Dashboard
Manage Tickers

ALXO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alx-oncology-holdings-to-present-updated-data-from-phase-2-aspen-06-trial-during-poster-session-at-sitc-annual-meeting
ALX Oncology Holdings To Present Updated D...
10/03/2025 13:08:39

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/22/2025 21:06:10

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 21:06:10

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 21:06:39

alx-oncology-announces-first-patient-dosed-in-phase-1-clinical-trial-for-alx2004-egfr-adc-that-is-being-studied-for-treatment-of-egfr-expressing-solid-tumors
ALX Oncology Announces First Patient Dosed...
08/19/2025 12:09:34

- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 12:08:33

why-palo-alto-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket
Why Palo Alto Shares Are Trading Higher By...
08/19/2025 12:01:09

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 21:06:15

alx-oncology-holdings-q2-adj-eps-044-beats-045-estimate
ALX Oncology Holdings Q2 Adj. EPS $(0.44) ...
08/12/2025 20:15:13

ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

alx-oncology-holdingss-earnings-a-preview
ALX Oncology Holdings's Earnings: A Preview
08/11/2025 18:03:08

ubs-maintains-buy-on-alx-oncology-holdings-lowers-price-target-to-1
UBS Maintains Buy on ALX Oncology Holdings...
05/21/2025 14:39:47

UBS analyst Colin Bristow maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $1.2 to $1.

alx-oncology-unveils-clinical-development-plans-for-alx2004-a-adc-targeting-egfr-expressing-tumors-with-phase-1-trials-set-for-mid-2025-following-fda-ind-clearance-and-initial-data-expected-in-1h-2026-while-advancing-cd47-blocker-evorpacept-in-breast-and-colorectal-cancer-trials-also-starting-mid-2025
ALX Oncology Unveils Clinical Development ...
05/20/2025 12:10:33

- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004...

hc-wainwright--co-maintains-buy-on-alx-oncology-holdings-lowers-price-target-to-2
HC Wainwright & Co. Maintains Buy on ALX O...
05/09/2025 11:10:21

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers t...

alx-oncology-holdings-q1-adj-eps-048-misses-046-estimate
ALX Oncology Holdings Q1 Adj. EPS $(0.48) ...
05/08/2025 12:46:26

ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

whats-next-alx-oncology-holdingss-earnings-preview
What's Next: ALX Oncology Holdings's Earni...
05/07/2025 16:10:00

alx-oncology-announces-final-results-from-phase-1-trial-evaluating-evorpacept-in-combination-with-standard-of-care-treatment-in-patients-with-b-cell-non-hodgkin-lymphoma--combination-generated-complete-responses-in-83-of-patients-with-indolent-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma
ALX Oncology Announces Final Results from ...
04/25/2025 17:15:31

Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology's investigational CD47-blocker, ev...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION